Fig 5 - uploaded by Christopher G. Wallace
Content may be subject to copyright.
The width of upper lip scar was measured by ultrasound, as indicated by the two green crosses. 

The width of upper lip scar was measured by ultrasound, as indicated by the two green crosses. 

Source publication
Article
Full-text available
Most patients with facial scarring would value even a slight improvement in scar quality. Botulinum toxin A is widely used to alleviate facial dynamic rhytides but is also believed to improve scar quality by reducing wound tension during healing. The main objective was to assess the effect of Botulinum toxin on scars resultant from standardized upp...

Context in source publication

Context 1
... and March 2012, sixty consecutive patients were enrolled for randomization having satisfied the following criteria. Inclusion criteria were: (1) adult (16 years or older) Oriental Taiwanese patients who desired elective CLSR surgery; (2) moderate-to-severe secondary scar deformity following primary cleft lip repair that warranted revision surgery; (3) valid written informed consent provided for surgery and trial inclusion. All CLSRs were performed at the Craniofacial Center of Chang Gung Memorial Hospital, Taiwan. A specialized nurse, who was independent of the study, prepared the encoded vials. Experimental group vials contained 0.6 ml of normal saline with 15 units of botulinum toxin A (ie. 100 units of botulinum toxin A per 4 ml of normal saline; Botox, Allergen Inc, Irvine, California). Vehicle-control group vials contained 0.6 ml of normal saline. All vials appeared identical except for their randomization code and patient identification. Patients were block randomized to a 1:1 ratio by an independent third-party specialized trials nurse into the experimental or vehicle-control group. Randomization codes were not revealed to anyone until after completion of the entire study. Patients, investigators, study personnel and outcomes assessors therefore remained blinded throughout the investigation (Fig. 2)(S1 Checklist). The lip scar was revised using a modified rotation advancement cheiloplasty as previously described [8]. Briefly, the scar of the lip and nasal floor was marked and the scar tissue narrowly excised. The orbicularis oris muscle was excised wider than the width of scar; this maneuver reduces tension across the overlying skin repair, since the muscle repair causes slight redundancy of the skin. The first stitch taking lateral orbicularis muscle was sutured to the nasal septum; thereafter, the lateral orbicularis muscle was interposed and sutured overlapping the medial orbicularis muscle for philtral column reconstruction. Interrupted sutures used were as follows: 4–0 and 5–0 polydioxanone (PDS II; Ethicon/Johnson-Johnson, New Brunswick, New Jersey) for muscle and subcuticular layers, respectively; 6-0 nylon (Unik, Taipei, Taiwan) for skin [8]. Immediately after skin closure, six injections of encoded vial content (0.1 ml for each injection site) were administered to the orbicularis oris muscle 5 mm either side of the wound below the nasal base and above the vermillion border (Fig. 3). Nylon sutures were removed six days postoperatively. To reduce wound tension caused by the adjacent risorius, zygomaticus major and zygomaticus minor muscles, both cheeks and the upper lip suture line were taped as per our routine for 6 months. Additionally, silicone sheeting was applied overnight as per our routine for 6 months. Compliance with both practices was consistent for all patients. All complications, such as hematoma, infection, wound dehiscence, oral incompetence, eating/drinking dysfunction and drug allergy, were logged if encountered. Primary and secondary end points were Vancouver scar scale (VSS) score (comprising the following components: pigmentation, vascularity, pliability and scar height), Visual analogue scale (VAS) and scar width, respectively. At six months follow-up, two plastic surgeons (PKTC and CSC) examined the patients in the outpatient clinic of Chang Gung Memorial Hospital. They were blinded to which group patients belonged. Scars were assessed using the VSS and assigned the mean score of the two observers. For photographs, one standard surgical ruler was placed over the lower lip and a frontally orientated photograph of the patient was taken at 6-months follow up. The same professional craniofacial medical photographer took all photographs. Patient’s photographs were subjectively assessed using VAS by five independent examiners (two Attending Plastic Surgeons and three laypersons). All examiners were both independent of the patients’ care and blinded to their treatments. They were asked to score the scars on the photographs using a standard Visual Analogue Scale (VAS) graded from 0 (worst possible scar) to 10 (best possible scar). Objective scar width measurements were performed using photography and ultrasonography. The scar was measured at two points with Photoshop (CS5 extended version 12.0; Adobe Systems Inc, San Jose, California) using the ruler as a control reference. The First Point was 1 mm above the white roll and the Second Point was 1 mm below the turning incision line, which is located close to the nasal sill (Fig. 4). The scar measurement was measured by two plastic surgeons and averaged. A commercial 12-MHz ultrasound transducer and imager (Model T3000; Terason, Northborough, MA, USA; settings: depth of penetration, 20 mm; capacity of ultrasound imager, 0.1 mm) was also used to quantify scar width. The transducer was placed with its upper border touching the columella-philtral junction, upper lip imaging was obtained and the scar width measured at the skin surface (Fig. 5). The ultrasound measurement was performed by the lead author (CSC) in duplicate and averaged. Inter-observer reliability of the VSS and VAS were tested using Cronbach a . Inter- observer reliability of photographic measurements was assessed with Pearson correlation by comparing two sets of measurements performed by two independent raters. Intra-observer reliability of ultrasound measurements was assessed with Pearson correlation by comparing two sets of measurements performed by the same rater. All statistical analyses were conducted using SPSS software (version 17.0; IBM Corporation, NY, USA). Differences between VSS scores, VAS and between scar widths obtained photographically and ultrasonographically were compared. The independent t-test was used to compare groups. Statistical significance was defined if p was less than 0.05. Data are presented as mean ¡ standard deviation unless otherwise stated. Thirty patients in the experimental group received botulinum toxin injections and thirty patients in the vehicle-control group received normal saline injections, as described, immediately after completion of CLSR. Fifty-eight patients completed six months of follow-up; two patients in the vehicle-control group failed to return for postoperative assessments. No complications were encountered (S1 Data). The mean ages for the experimental group and vehicle-control group were 24.70 ¡ 7.16 versus 21.87 ¡ 8.00. There were 12 males and 18 females with 20 left and 10 right cleft lips in the experimental group. There were 14 males and 14 females with 20 left and 8 right cleft lips in the vehicle control group. The VSS score for the experimental group was significantly lower than that of the vehicle-control group (2.45 ¡ 1.52 versus 3.50 ¡ 1.88; p 5 0.023). Inter- observer consistency in using the VSS score was high (Cronbach a 5 0.936). The VAS score in the experimental group was significantly better than in the vehicle-control group (7.47 ¡ 0.64 versus 6.10 ¡ 1.06; p , 0.001). Inter-observer consistency was high (Cronbach a 5 0.923) According to photographic measurements, the scar was significantly narrower at both the First Point (0.62 ¡ 0.18 mm versus 0.95 ¡ 0.31 mm; p , 0.001) and the Second Point (0.63 ¡ 0.18 mm versus 0.92 ¡ 0.36 mm; p , 0.001) in the experimental than in the vehicle-control group. Inter-observer consistency was high for the photographic data (First Point: r 5 0.87, p , 0.001; Second Point: r 5 0.88, p , 0.001). This was also the case according to ultrasonographic measurements (0.72 ¡ 0.25 mm versus 1.03 ¡ 0.42 mm for experimental and vehicle-control groups respectively; p 5 0.001). Intra-observer consistency was high for the ultrasonographic data (r 5 0.90, p , 0.001). Facial scars can be cosmetically disfiguring and may, in some patients, cause functional impairment and psychosocial withdrawal [9, 10]. Cutaneous scars are generally distinguished from surrounding normal skin by differences in color, thickness, contour, compliance, overall cosmesis and functional detriments such as contracture formation. Young et al found that patients were usually dissatisfied with their surgical scars, irrespective of patient gender, age, ethnicity or geographical location, and that 91% of them would value even a small improvement in their scar [3]. Hence, surgeons frequently recommend and prescribe scar modulation practices and treatments, particularly in susceptible ethnicities such as Orientals for whom the incidence of unfavorable scarring is higher than in Caucasians [11]. Synergistic contractions of the facial muscles are responsible for facial expressions. Since these muscles do not have bony insertions and lie very superficially, their actions exert tension across adjacent skin and subcutaneous tissue. If a wound is orientated perpendicular to the direction of the underlying facial muscle fibers, the muscular tension exerts a distracting effect on the healing wound edges and increases the risk of an undesirable hypertrophic or widened scar (Fig. 1). Consequently, reducing tension around a wound is important for improving scar quality and reducing the incidence of hypertrophic scars [12, 13]. A secondary cleft lip deformity is one that arises despite primary surgical treatment of the cleft lip. The principles of CLSR are cleft scar excision, anatomical repair of the orbicularis oris muscle, and correction of asymmetries noted in the Cupid bow and philtral columns. Unfortunately, CLSR wounds are unavoidably orientated perpendicular to the line of pull of the subjacent orbicularis oris muscle, which is in constant use during daily life for speech, eating, drinking, blowing, sucking, and a variety of facial expressions. These repetitive bouts of distracting tensional forces inflict micro-trauma to the healing wound, leading to prolongation of the inflammatory response and ultimately increased fibrosis [14]. In contrast to other facial wounds, the incidence of hypertrophic scars affecting the ...

Similar publications

Article
Full-text available
As there is currently no internationally accepted outcome measurement tool available for complete bilateral cleft lip and palate (CBCLP), the goal of this prospective study was to develop a numerical evaluation scale that allows reliable scoring of this cleft deformity. Our cohort comprised 121 Indian subjects with CBCLP who underwent surgical repa...
Article
Full-text available
Introduction . This study compared the healing efficacy and possible adverse effects of topical Alpha and medical-grade honey ointments on cutaneous wounds in rats. Methods . To conduct the study, 22 male Sprague-Dawley rats were randomly allocated into two equal groups: (1) rats with Alpha ointment applied to the wound surface area and (2) rats wi...

Citations

... For meta-analysis, selected data of 18 RCTs studies were of good quality (►Table 1) on the efficiency of the BTA use in pathologic scars treatment and prevention cases. [9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26] In total, data on 363 cases of the BTA use for prevention of scars were analyzed. The age of the patients ranged from 6 to 68 years, average 37.3. ...
Article
Full-text available
Objective To evaluate the possibility of improving and preventing the formation of postoperative hypertrophic and keloid scars using botulinum toxin type A (BTA). Materials and Methods Scientific articles published in English have been systematically screened in PubMed/MEDLINE database over the entire period. The following information about the studies was analyzed: first author surname; year of publication; number of patients; average age; scar location; dosage of the drug administered; follow-up duration; scar assessment methods; results, incidence of hypertrophic and keloid scars formation. The odds ratio and 95% confidence interval were calculated for each of the estimated parameters. The statistical heterogeneity of publications assessed using the criteria of chi-square test and I 2. The differences were considered significant at p < 0.05. Results A total of 18 prospective randomized studies were selected for evaluation, containing data on the use of BTA in 363 cases. Patients receiving botulinum toxin had a lower Vancouver scar scale index, higher visual analog scale index, and higher Stony Brook scar evaluation scale score. The use of BTA reduces the risk of perceptible scar formation, the incidence of hypertrophic and keloid scars. Conclusion The use of BTA to obtain imperceptible scar and prevent hypertrophic and keloid postoperative scars demonstrates good prospects. However, there is no consensus regarding the pathophysiological mechanisms underlying the positive effect of BTA on the prevention of hypertrophic and keloid scars.
... The scar was assessed at period of two weeks, three months and six months postoperatively via VSS (22), VAS (23), scar widths and lip height measurements (23,24). ...
... other studies. For instance, Chang et al. found a significant improvement in the scar scores after botulinum toxin injections.29 ...
Article
Introduction Folinic acid and botulinum toxin A have shown promising results in wound healing in different studies. This study aimed to compare the effects of these approaches on wound healing after simulating cleft lip surgery in rats. Methods In this experimental animal study, after creating lip defects, 30 rats were randomly divided into three groups and received normal saline (CTL), botulinum toxin A (BOT), and folinic acid (FOL). Biopsy from the skin wounds was performed after 14‐ and 28‐days. These samples were stained with haematoxylin and eosin and Masson trichrome staining. Finally, each pathological parameter of wound healing was rated in this study. Results While the inflammatory response was not different among the study groups, fibroblast proliferation and collagen deposition were significantly higher in FOL group compared to BOT group. Moreover, both BOT and FOL facilitated epithelial healing and 14‐day angiogenesis as compared with normal saline. Conclusions Improved wound healing was observed using both botulinum toxin A and folinic acid in rat animal models. However, the application of botulinum toxin A caused less fibroblast proliferation and collagen deposition which can potentially lead to less scar formation, which can be particularly important in the aesthetic zone.
... Another aspect to consider is the timing of BoNT-A administration. While previous studies have predominantly administered BoNT-A either before wound closure, immediately after wound closure, or during the early postoperative phase [14,19,25,[37][38][39], our study uniquely opted for injection 14 days after surgery. This variation in timing could potentially influence the efficacy of BoNT-A, introducing a factor that may have impacted the outcomes observed in our study. ...
Article
Full-text available
Background: Subcutaneous mastectomies in transmen have been gaining popularity. However, post-operative scars are an inevitable consequence. Recently, Botulinum neurotoxin A (BoNT-A) has shown positive effects in scar prevention. The objective of this study is to investigate the effectiveness of BoNT-A in scar prevention. Methods: Fifteen patients who had undergone subcutaneous mastectomy were included. At 14 days post-surgery, either incoBoNT-A or a placebo was injected into the scar on each side. The primary outcome assessment measured the scar's severity using the Vancouver Scar Scale (VSS) and the Patient and Observer Scar Assessment Scale (POSAS). The secondary outcome assessment evaluated the scar's color using a standard measurement device. Outcome assessments were conducted until 6 months post-surgery. Results: There were significantly lower VSS scores in the BoNT-A group compared to the placebo at the end of the study (7.43 ± 0.26 vs. 8.82 ± 0.26, p < 0.001). The objective assessment revealed a statistically significant decrease in redness values in the BoNT-A group compared to the placebo at 3 and 6 months. Conclusion: BoNT-A has demonstrated effectiveness in scar prevention by reducing the severity of postoperative scar formation and improving overall scar appearance.
... As already mentioned, a modified LRS approach is to combine the surgical treatment with BTX injections. The combination of BTX, used with the intent to minimize tension from the musculature during wound healing, with an upper lip surgical procedure where increased tension during the early postoperative period could lead to greater scarring, was first applied during cheiloplasties to correct cleft lip defects [114][115][116]. The results showed better scar quality (less wide, better appearance) when BTX was used [115,116]. ...
... The combination of BTX, used with the intent to minimize tension from the musculature during wound healing, with an upper lip surgical procedure where increased tension during the early postoperative period could lead to greater scarring, was first applied during cheiloplasties to correct cleft lip defects [114][115][116]. The results showed better scar quality (less wide, better appearance) when BTX was used [115,116]. The combination of BTX and LRS for GS treatment was first reported in 2016 by Aly and Hammouda [117], who applied BTX two weeks following LRS. ...
... Therefore, decrease in activity of the muscle which in turn reduces the tension on the skin during healing may improve the appearance of the resultant scar. 7 Temporary muscle relaxation by injection botulinum toxin might be beneficial in wound healing improvement. 8 Botulinum toxin which is a strong neurotoxin derived from Clostridium botulinum, its use had been approved to be safe and effective in treatment of many disorders. ...
Article
Full-text available
Background & Objectives: Cleft lip and palate are common congenital anomalies that require precise management with main component of repairing lip is the aesthetic outcome. Using botulinum toxin is new method to optimize the resultant scar. The aim of this study is to evaluate the effect of botulinum toxin type A following cleft lip repair on resultant quality of scar. Methods: This is a comparative study conducted in Rizgary teaching hospital and private hospitals in Erbil – Kurdistan region/Iraq between July 2018 and April 2021. A total of 38 patients with cleft lip were included; bilateral and unilateral, complete and incomplete, isolated cleft lip and cleft lip and palate, 20 of them received botulinum toxin injection. Preoperative and postoperative photos were documented. Scars were analysed one year following repair. Results: Among 38 patients, in comparison of outcome of using botulinum toxin (31.6%) following cleft lip repair to patients did not receive the injection (68.4%), the scar quality was better; linear scar in botox group 100%, non-botox group 80.8%, complications were less; early complications in botox group 8.3%, non-botox group 11.5% and late complications in botox group 0% non-botox 7.7% and satisfaction was better; parents of botox group were 100% highly satisfied while for those of non-botox group 84.6% highly satisfied, 7.7% satisfied and 7.7% unsatisfied. There was significant difference between the two groups but statistically not significant. Conclusion: Botulinum toxin injections into the subjacent orbicularis oris muscle following cleft lip repair produced better appearing and narrower cheiloplasty scars.
... Two trials reported the average age i.e. 4.82±1.47 (19) and 3.17 ±0.25 (20) in months respectively. In two trials, patients received BTXA injections right away following surgery. ...
... In two trials, patients received BTXA injections right away following surgery. 20,21 One trial reported injections before surgery. 19 The gender distribution was reported in two trials (Table 1). ...
... 19 The gender distribution was reported in two trials (Table 1). 19,20 VSS score Patients treated with BTXA had less VSS scores as compared to the control group at 3 months. Fifty-five patients from the experimental group and 54 cases from the control group were included in the metaanalysis of reported VSS scores. ...
... They concluded that botulinum toxin A injection in the orbicularis muscle after cleft lip repair gives a narrow scar with a better appearance. 12 Orbicularis oris muscle denervation through use of botulinum toxin A injection was proved by Galarvaga 13 , when he subjected five children with cleft lip to injection of 10 units of botulinum toxin A into the upper lip during surgery. Before surgery, an electromyographic study was done for all patients, and its finding was compared with postoperative electromyographic findings. ...
Article
Full-text available
Background: Cleft lip deformity is one of the most common congenital anomalies. Repair of cleft lip may create too much tension especially when done in wide cleft lip, and this may result in unacceptable scar. Aim of study: To evaluate the efficacy of botulinum toxin in reducing or preventing post cheiloplasty hypertrophic scar. Patient and method: Between the period from October 2019 to August 2021, 10 patients with cleft lip were subjected to primary cheiloplasty using Millard rotation advancement flap technique followed by botulinum toxin injection into the site of repair. Follow up period was 6 months postoperatively. Results: All of our patients showed excellent result which was evaluated using visual analogue scale assessment which was done by tow independent surgeons. Our patients showed barely visible scar at 6 months postoperatively with no recorded hypertrophic scar. No side effect was recorded related to botulinum toxin injection. Conclusion: Botulinum toxin injection after primary cheiloplsty showed to be safe and effective in prevention of development of unacceptable hypertrophic scar. Keywards: botulinum, cleft lip, hypertrophic scar, cheiloplasty.
... Many efforts were made to minimize the scar following initial cleft lip surgery by employing botulinum toxin (Botox), scar-reducing gel, and fat grafting. 4 However, Botox and scar reduction gel are artificial materials that are quite costly. Furthermore, fat grafting surgery is not appropriate for all individuals. ...
... 15 As a result, Zhang et al. 16 employed ultrasonography to better understand the nature of the upper lip orbicularis oris muscle and to offer clinical data for assessing the outcome of cleft lip repair surgery. Additionally, Chang et al. 4 and Nuridinovich 17 used ultrasonography to determine scar breadth following cleft lip surgery. ...
... This research used PRP during the surgical intervention to measure scar width in children less than 6 months old with unilateral complete or partial cleft lips. According to a prior work by Chang et al., 4 the scar's breadth was 0.33e0.25 mm smaller on the side of the intervention. A total of 30 patients, 15 in each group, were required at an 80% power and a 5% significance level to be the sample size. ...
... The treatment of cleft lip scars involves both non-surgical and surgical methods. The nonsurgical methods include mechanical intervention [6], laser treatment [7], and the usage of chemical substances [8] (e.g., silicone-based products, botulinum toxin injections into muscles, and laser therapy). ...
Article
Full-text available
Objectives The current study aimed to evaluate the effectiveness of plasma skin regeneration (PSR) in the treatment of cleft lip scars in cleft lip patients. Materials and methods Twenty patients, 10 females and 10 males, with a mean age of 19 years and who had a cleft lip scar, were included in the current study. All patients were treated with a plasma skin regeneration pen device in one treatment session. The thickness, relief, and pliability of the scars were assessed by external observers using a 10-point numeric rating scale (NRS). Results The thickness, relief, and pliability of the scar were significantly improved according to the observers’ opinions (51.67%, 50.25%, and 46.33%, respectively). Conclusions Within the limits of this study, the PSR appeared to be safe and effective for treating cleft lip scars with minimal complications.